Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study
Willem A. Mak, Johannes G.M. Koeleman, Marijke van der Vliet, et al.
Journal of Infection (2021) Vol. 84, Iss. 2, pp. 171-178
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
Epidemiological and clinical perspectives of long COVID syndrome
Katherine Huerne, Kristian B. Filion, Roland Grad, et al.
American Journal of Medicine Open (2023) Vol. 9, pp. 100033-100033
Open Access | Times Cited: 46
Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics
Maddy L. Newby, Carl A. Fogarty, Joel D. Allen, et al.
Journal of Molecular Biology (2022) Vol. 435, Iss. 4, pp. 167928-167928
Open Access | Times Cited: 44
Interim safety and immunogenicity analysis of the EuCorVac‐19 COVID‐19 vaccine in a Phase 3 randomized, observer‐blind, immunobridging trial in the Philippines
Jonathan F. Lovell, Kazutoyo Miura, Yeong Ok Baik, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Closed Access | Times Cited: 3
Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients
Lucrezia Furian, Francesco Paolo Russo, Gianluigi Zaza, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Sabina Zurac, Cristian Vlădan, Octavian Dincă, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Complete (Humoral and Cellular) Response to Vaccination against COVID-19 in a Group of Healthcare Workers-Assessment of Factors Affecting Immunogenicity
Ewa Morgiel, Magdalena Szmyrka−Kaczmarek, Marta Madej, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 710-710
Open Access | Times Cited: 11
Enriched CXCR3+ CXCR5+ CD8+ T cells in SARS-CoV-2 infected and vaccinated individuals effectively respond to the antigen in recall
Pengcheng Zhou, Fang Gong, Tuo Ji, et al.
Journal of Infection (2023) Vol. 86, Iss. 5, pp. 497-499
Open Access | Times Cited: 6
Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2
Jackelinne Y. Hayashi, Adriana Simizo, Jackson Gabriel Miyamoto, et al.
Journal of Infection (2022) Vol. 84, Iss. 6, pp. 834-872
Open Access | Times Cited: 9
Analysis of Cell Immunity for Children Infected with SARS-CoV-2 and Those Vaccinated against SARS-CoV-2 Using T-SPOT®.COVID
Tomohiro Oishi, Yuto Yasui, Atsushi Kato, et al.
Microorganisms (2024) Vol. 12, Iss. 5, pp. 975-975
Open Access | Times Cited: 1
Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers
Isabell Wagenhäuser, Giovanni Almanzar, Franziska Bernhardine Förg, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126132-126132
Open Access | Times Cited: 1
Dynamics of Antibody and T Cell Immunity against SARS-CoV-2 Variants of Concern and the Impact of Booster Vaccinations in Previously Infected and Infection-Naïve Individuals
Michel R. Faas, Willem A. Mak, Hilde Y. Markus, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2132-2132
Open Access | Times Cited: 8
Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study
Clara Schnizer, Nico Andreas, Wolfgang Vivas, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 4
Humoral responses after primary and booster SARS‐CoV‐2 inactivated vaccination in patients with chronic hepatitis B virus infection: A longitudinal observational study
Zhiwei Chen, Tianquan Huang, Taiyu He, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 4
Ancestral SARS‐CoV‐2 and Omicron BA.5‐specific neutralizing antibody and T‐cell responses after Omicron bivalent booster vaccination in previously infected and infection‐naive individuals
Willem A. Mak, Wendy Visser, Marijke van der Vliet, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 4
Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management
Guillem Safont, Irene Latorre, Raquel Villar-Hernández, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5103-5103
Open Access | Times Cited: 7
Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19
Mai Hashem, Mohamed El‐Kassas
World Journal of Clinical Cases (2023) Vol. 11, Iss. 10, pp. 2140-2159
Open Access | Times Cited: 3
Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination
Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim, et al.
Journal of Infection (2022) Vol. 85, Iss. 5, pp. 573-607
Open Access | Times Cited: 5
The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients
Lei Yang, Feng Xiang, Dian Wang, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 4, pp. 503-512
Open Access | Times Cited: 2
Machine Learning Classification of Time since BNT162b2 COVID-19 Vaccination Based on Array-Measured Antibody Activity
MA Qing-lan, Huang Fei-ming, Wei Guo, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1304-1304
Open Access | Times Cited: 2
Longitudinal age differences in humoral responses to the COVID-19 vaccine in the elderly are lost after the third dose
María del Mar Pozo‐Balado, Ángel Bulnes‐Ramos, Vanesa Garrido‐Rodríguez, et al.
Journal of Infection (2022) Vol. 86, Iss. 2, pp. 154-225
Open Access | Times Cited: 4
Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh
Marjahan Akhtar, Salima Raiyan Basher, Nuder Nower Nizam, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Analysis of Cell Immunity for Children Infected with COVID-19 and Those Vaccinated against COVID-19 Using T-SPOT®.COVID
Tomohiro Oishi, Yuto Yasui, Atsushi Kato, et al.
(2024)
Open Access
Short-term effects of vaccination againstCOVID-19 on humoral and cellularimmune response in adults
D. Siedlecka, Aleksandra Baszczuk, Aleksandra Ludziejewska, et al.
Diagnostyka Laboratoryjna (2024) Vol. 60, Iss. 4, pp. 249-258
Closed Access
Page 1 - Next Page

Scroll to top